Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
Sponsor: Bristol-Myers Squibb
Summary
This observational study aims to assess pregnancy and infant outcomes among pregnant women with psoriasis who have been exposed to deucravacitinib treatment in the USA.
Official title: Deucravacitinib Pregnancy Study: A Retrospective Observational Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
Key Details
Gender
FEMALE
Age Range
15 Years - 50 Years
Study Type
OBSERVATIONAL
Enrollment
833
Start Date
2024-08-02
Completion Date
2029-02-28
Last Updated
2024-11-29
Healthy Volunteers
No
Conditions
Interventions
Deucravacitinib
As per product label
Systemic psoriasis medications
As per product label
No systemic medications
Participants not exposed to any systemic medications
Locations (1)
Bristol-Meyers Squibb
Lawrenceville, New Jersey, United States